Rege Nephro
Series B in 2024
Rege Nephro is a Kyoto-based biotechnology company focused on renal disease therapeutics. It conducts research and development, production, and marketing of therapies based on nephron progenitor cells, and develops kidney organoids used to screen nephrotoxicity in drug discovery. The company is leveraging induced pluripotent stem cell technology from the Center for iPS Cell Research and Application at Kyoto University to develop cell-based therapies for kidney conditions, along with potential applications for liver and pancreas diseases. Founded in 2019, Rege Nephro aims to reduce dialysis dependence by addressing renal failure through regenerative approaches.
Co-LABO MAKER
Series A in 2023
Co-LABO MAKER is a Japanese company that operates a sharing platform for laboratory equipment and related technologies. Founded in 2017 and based in Sendai, it enables researchers and laboratories to access underutilized tools at lower cost by matching equipment owners with users. The company supports experiments, prototyping, and the creation of samples, providing end-to-end assistance from planning and fundraising to implementation of research and development projects that utilize its technology. Through its platform, it aims to streamline access to resources and maximize utilization of laboratory assets, helping researchers advance projects without significant upfront investment.
LUCA Science
Series B in 2022
LUCA Science Inc. is a biotechnology company based in Japan that specializes in developing innovative mitochondrial therapies aimed at restoring cellular bioenergetics in damaged tissues and organs. Utilizing patented iMIT technology, the company creates a novel platform of highly functional mitochondria, which can be supplied to affected areas to enhance bioenergetics and restore normal cellular functions. By harnessing mitochondria as biopharmaceutical agents, LUCA Science aims to address a range of unmet medical needs and improve disease states through the stabilization and control of mitochondrial activity. This groundbreaking approach positions LUCA Science at the forefront of mitochondrial therapy, with the potential to significantly impact the treatment landscape for various health conditions.
Koala Tech
Venture Round in 2021
Koala Tech Inc. is a high-tech startup based in Fukuoka, Japan, founded in 2019. The company specializes in the development of organic semiconductor laser diodes, a pioneering technology that emerged from research at the Center for Organic Photonics and Electronics Research at Kyushu University. Koala Tech's innovative approach utilizes organic fluorescent semiconductors, which are easier and less harmful to process into thin films. This technology offers a low-cost light source that can be seamlessly integrated into OLED and organic electronic platforms, aiming to create practical applications for these advanced laser diodes.
DAIZ Inc. is a Japanese company founded in 2015, specializing in the production and supply of plant-based meat products. Based in Kumamoto, the company offers a product line known as "Miracle Meat," which utilizes germinated soybeans through its proprietary Ochiai Germination Method. DAIZ focuses on creating plant-based substitutes for traditional meat dishes, providing consumers with healthy and cruelty-free alternatives. In addition to its production efforts, the company also engages in research and development related to raw materials and drug discovery derived from germinated soybeans.
SUDx-Biotec
Venture Round in 2020
SUDx-Biotec Corp. is a Japanese company, established in 2006 and headquartered in Kagoshima, that specializes in the research, development, and commercialization of sugar chain technology. The company focuses on creating innovative diagnostic systems for the sensitive detection of viruses, utilizing glycine identification technology to enhance the accuracy of its testing platforms. SUDx-Biotec has developed an electricity-free diagnostic kit aimed at improving virus testing standards, specifically targeting active viral envelopes to aid healthcare providers in diagnosing and treating cold-like conditions. Additionally, the company offers reagents for research and conducts commissioned experiments, including virus testing, contributing to advancements in the field of medical diagnostics.
Space Walker
Seed Round in 2020
Space Walker Inc. is a Tokyo-based company founded in 2017 that specializes in the design, manufacture, and sale of reusable winged sub-orbital space planes and associated components. The company aims to facilitate safe and efficient travel to outer space and small satellite launches through its innovative technology. In addition to its manufacturing activities, Space Walker proposes and plans various space-related events, further expanding its involvement in the aerospace sector.
Koala Tech
Venture Round in 2020
Koala Tech Inc. is a high-tech startup based in Fukuoka, Japan, founded in 2019. The company specializes in the development of organic semiconductor laser diodes, a pioneering technology that emerged from research at the Center for Organic Photonics and Electronics Research at Kyushu University. Koala Tech's innovative approach utilizes organic fluorescent semiconductors, which are easier and less harmful to process into thin films. This technology offers a low-cost light source that can be seamlessly integrated into OLED and organic electronic platforms, aiming to create practical applications for these advanced laser diodes.
KiQ Robotics
Seed Round in 2019
KiQ Robotics Inc. is a Japan-based company that specializes in the research, development, and sales of industrial robotics equipment. Founded in 2019 in Kitakyushu, the company produces a general-purpose robot hand equipped with flexible fingertips and advanced three-dimensional sensors. KiQ Robotics also focuses on creating systems that allow users to program robotic movements using natural language and gestures. In addition to its robotic hardware, the company offers cloud services that connect users to its system network. KiQ Robotics aims to enhance automation capabilities, enabling robots to perform a variety of tasks in real-time that traditionally required human intervention, thereby increasing efficiency and reducing labor costs in various industrial applications.
SUDx-Biotec
Venture Round in 2019
SUDx-Biotec Corp. is a Japanese company, established in 2006 and headquartered in Kagoshima, that specializes in the research, development, and commercialization of sugar chain technology. The company focuses on creating innovative diagnostic systems for the sensitive detection of viruses, utilizing glycine identification technology to enhance the accuracy of its testing platforms. SUDx-Biotec has developed an electricity-free diagnostic kit aimed at improving virus testing standards, specifically targeting active viral envelopes to aid healthcare providers in diagnosing and treating cold-like conditions. Additionally, the company offers reagents for research and conducts commissioned experiments, including virus testing, contributing to advancements in the field of medical diagnostics.
Koala Tech
Venture Round in 2019
Koala Tech Inc. is a high-tech startup based in Fukuoka, Japan, founded in 2019. The company specializes in the development of organic semiconductor laser diodes, a pioneering technology that emerged from research at the Center for Organic Photonics and Electronics Research at Kyushu University. Koala Tech's innovative approach utilizes organic fluorescent semiconductors, which are easier and less harmful to process into thin films. This technology offers a low-cost light source that can be seamlessly integrated into OLED and organic electronic platforms, aiming to create practical applications for these advanced laser diodes.
DAIZ Inc. is a Japanese company founded in 2015, specializing in the production and supply of plant-based meat products. Based in Kumamoto, the company offers a product line known as "Miracle Meat," which utilizes germinated soybeans through its proprietary Ochiai Germination Method. DAIZ focuses on creating plant-based substitutes for traditional meat dishes, providing consumers with healthy and cruelty-free alternatives. In addition to its production efforts, the company also engages in research and development related to raw materials and drug discovery derived from germinated soybeans.
Sports Sensing
Venture Round in 2018
Sports Sensing Co., Ltd., established in 2015 and located in Fukuoka City, Japan, specializes in the manufacture and sale of advanced technology hardware, including display monitors and sensors. The company focuses on developing wireless sensing technology aimed at enhancing athletic performance by logging physical movement and biological signal data. This technology allows players, instructors, and analysts to conduct thorough research and analysis, thereby improving competitiveness across various sports. By providing quantitative insights into performance metrics, Sports Sensing enables its clients to gain a deeper understanding of their capabilities and areas for improvement.
Chromocenter
Venture Round in 2018
Chromocenter Inc. is a biopharmaceutical company based in Yonago, Japan, established in 2005. The company specializes in developing artificial chromosome technologies, primarily focusing on applications within the life sciences sector. Chromocenter's innovative approach utilizes artificial chromosome vectors to facilitate drug discovery and the construction of stable gene expression cell lines, which are essential for high protein production. Additionally, the company offers services such as chromosome analysis and various forms of fluorescence in situ hybridization (FISH), including multicolor and monochrome analysis. Through its advanced technologies, Chromocenter aims to provide clinicians with safe and effective pharmaceuticals for treating a range of diseases.
Jeplan
Venture Round in 2018
Jeplan, Inc. is a Japanese company specializing in recycling technologies and systems aimed at promoting sustainable practices. Founded in January 2007 and based in Tokyo, it develops innovative solutions that cater to diverse consumer needs. The company utilizes proprietary chemical recycling technology to transform waste materials, such as food packaging and plastic PET bottles, into recycled polyethylene terephthalate (r-PET) resin and Bis(2-Hydroxyethyl) terephthalate (r-BHET) resin. These recycled materials are then used in the manufacturing of various products, including PET bottles and textiles. In addition to its technological advancements, Jeplan is involved in promoting the recycling of used uniforms and offers consulting services to businesses looking to implement recycling initiatives. Through its efforts, Jeplan aims to enhance recycling efficiency and contribute to environmental sustainability.
Kotozna
Venture Round in 2018
Kotozna, Inc. is an innovative IT service company based in Tokyo, Japan, founded in 2016. The company specializes in developing mobile applications that provide real-time multilingual translation services, addressing the social challenge of language barriers. Its flagship product, Kotozna Chat, allows users to communicate across various messaging platforms with instantaneous translation, facilitating seamless interaction for international travelers and local businesses. Additionally, Kotozna offers Kotozna Camera, which translates Japanese content, such as restaurant menus, through QR code scanning. By leveraging advanced technologies like AI and machine translation, Kotozna aims to enhance communication for enterprises and enable them to effectively engage with customers in a global market.
Himuka AM Pharma
Venture Round in 2017
Himuka AM Pharma Corp. is a pharmaceutical company based in Miyazaki City, Japan, established in February 2017. The company focuses on the research, development, and discovery of drug candidates derived from adrenomedullin, a bioactive peptide initially identified at the University of Miyazaki. Himuka AM Pharma aims to create innovative therapies that target mucosal healing and clinical remission, addressing significant unmet medical needs in healthcare. Through its specialized approach to developing adrenomedullin derivatives, the company seeks to contribute meaningfully to advancements in medical treatments.
Cyfuse Biomedical
Venture Round in 2017
Cyfuse Biomedical specializes in developing tissue fabrication systems and cell-based products for global research institutions. It offers a robotic 3D BioFabrication system, producing various tissue grafts for therapeutic use, drug development, and research purposes. Founded in 2010, the company is headquartered in Tokyo, Japan.
Goryo Chemical
Venture Round in 2016
Goryo Chemical, Inc. is a Japanese company specializing in the development of fluorescent probes and functional dyes for applications in chemical biology and diagnostics. Founded in 2010 and headquartered in Sapporo, with an additional office in Tokyo, the company offers a range of products including AcidiFluor, CalFluor, GlycoFluor, and MetalloFluor, among others. These fluorescent probes are designed for cellular analysis, assay, and imaging, enabling selective staining of acidic organelles such as lysosomes and late endosomes. Goryo Chemical also provides bioluminescent probes, labeling services, and custom synthesis, catering to various needs in molecularly-targeted drug and immunoassay applications. The company serves its customers through a network of distributors both domestically and internationally.
SENTAN Pharma
Venture Round in 2016
SENTAN Pharma Inc. is a biotechnology company focused on drug discovery and the development of nanoparticle formulations, particularly targeting cardiovascular diseases. Established in 2007 and based in Fukuoka, Japan, the company conducts research and development of ethical drugs, medical devices, and quasi-drugs. SENTAN Pharma manufactures and sells health supplements alongside specially controlled medical devices. Its product portfolio includes PLGA Nano-particle, Pitavastatin-Nano particle for conditions such as chronic critical limb ischemia and acute myocardial infarction, Cyclosporin-Nano particle aimed at treating acute myocardial infarction and stroke, and a third nanoparticle formulation for diabetes and obesity. By leveraging nanotechnology, SENTAN Pharma aims to create innovative pharmaceuticals and medical devices, bridging the gap between academic research and industrial application.
Kyulux is a material developer that researches and sells organic electroluminescence materials for OLED displays and lighting. The company specializes in thermally activated delayed fluorescence (TADF) emitters and Hyperfluorescence technology that combines TADF with fluorescent emitters to achieve high efficiency. Kyulux develops and supplies OLED materials and related solutions to manufacturers in the display and lighting industries, enabling cost-effective, durable, and efficient OLED devices without rare metals. Founded in 2015 and headquartered in Fukuoka, Japan, Kyulux owns or controls a substantial portfolio of TADF intellectual property developed with Kyushu University and industry partners, supporting the commercial adoption of next-generation OLEDs.